Integrated Medicine for Sepsis: An RCT With Phenotyping
Key facts
- Who runs it
- Henan University of Traditional Chinese Medicine
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 320 people, planned
- Started
- 2 Nov 2026
- Expected to end
- 31 Dec 2029
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Syndrome-Differentiated Chinese Herbal Medicine
- Matching Placebo for Syndrome-Differentiated Chinese Herbal Medicine
- Record updated
- 6 November 2026
Who can take part
- Age
- 18 years to 79 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age ≥18 years and <80 years
- Meeting the Sepsis-3.0 definition and diagnostic criteria for sepsis, with a Sequential Organ Failure Assessment (SOFA) score of 2-13
- Patients with pulmonary infection or bloodstream infection
- Meeting the diagnostic criteria for one of the following traditional Chinese medicine syndrome patterns: phlegm-heat obstructing the lung syndrome, exuberant heat-toxin syndrome, Yangming bowel excess syndrome, or stasis-toxin obstructing the collaterals syndrome
- Written informed consent provided by the patient or the patient's legally authorized representative/family member
Who cannot take part
- Use of immunosuppressive therapy or receipt of organ transplantation within the previous 3 months
- Participation in another interventional drug clinical trial within 1 month prior to enrollment
- Patients with severe underlying diseases, including unresectable malignancies, hematologic diseases, or human immunodeficiency virus (HIV) infection
- Known allergy or hypersensitivity to any of the study medications
- Patients with trauma, including fractures, burns, hepatic rupture, splenic rupture, or other major traumatic injuries
- Pregnant or breastfeeding women
- Severe hepatic or renal dysfunction, defined as a score ≥3 in the hepatic or renal component of the SOFA score
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 79 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the clinical efficacy and safety of integrated traditional Chinese and Western medicine in the treatment of sepsis, explore its potential value in improving clinical outcomes, and provide high-quality clinical evidence for the integrated management of sepsis.In addition, blood samples will be collected for phenotyping and subsequent transcriptomic, proteomic, and metabolomic analyses.
The 2 groups in the trial
- Standard Western Medicine Plus Syndrome-Differentiated Chinese Herbal MedicineTreatment being tested
Participants will receive standard Western medical treatment for sepsis in combination with syndrome-differentiated Chinese herbal medicine according to the study protocol.
Treatment: Syndrome-Differentiated Chinese Herbal Medicine
- Standard Western Medicine Plus Matching PlaceboPlacebo, for comparison
Participants will receive standard Western medical treatment for sepsis in combination with a matching placebo of the syndrome-differentiated Chinese herbal medicine according to the study protocol.
Treatment: Matching Placebo for Syndrome-Differentiated Chinese Herbal Medicine
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy of Integrated Chinese and Western Medicine for Sepsis With Phenotypic Profiling: A Randomized Controlled Trial
- Criteria questions
- Built from NCT07920692, who can take part
- Record updated
- 6 November 2026